Neuropharmacology researchers are scientists who study how drugs affect the nervous system, aiming to understand and develop treatments for neurological and psychiatric disorders. Their work focuses on the interaction between chemicals and neural pathways to uncover how various substances influence brain function, behavior, and cognition. These researchers explore the mechanisms of action of neurotransmitters, receptors, and ion channels, and investigate how different compounds can modulate these targets to alleviate symptoms or alter disease progression. Neuropharmacology bridges multiple disciplines including biology, chemistry, and medicine, making it a critical field for advancing treatments for conditions such as depression, epilepsy, Parkinson’s disease, Alzheimer’s, and chronic pain.
Neuropharmacology researchers conduct experiments using cell cultures, animal models, and clinical trials to test new drugs and understand their effects on the nervous system. Their discoveries often lead to the development of safer and more effective medications, improving the quality of life for patients with complex neurological diseases. Collaboration with neurologists, psychiatrists, and pharmaceutical companies is essential to translate basic research into clinical therapies. Advances in neuropharmacology have contributed to the creation of targeted treatments that minimize side effects and enhance efficacy. As brain disorders continue to pose significant challenges, neuropharmacology researchers play a vital role in unlocking new therapeutic possibilities and shaping the future of neurological medicine.
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : In silico in vitro and in vivo study of geraniol role in Alzheimer's disease
Bhuvanesh Baniya, Mohanlal Sukhadia University, India
Title : Prince transform: a wave-mechanical framework for real-time EEG analysis and early seizure prediction using chirp and drift detection
Mustafa A Khan, Sevaro Health Inc., United States
Title : Gut-brain axis in autism spectrum disorder: MicroRNAs as a critical mediator of pathogenesis
Rahem Rahmati, Shahrekord University of Medical Sciences, Iran (Islamic Republic of)